Notice of Correction to PAR-14-245 "Translational Programs in Lung Diseases (P01)"

Notice Number: NOT-HL-14-226

Key Dates
Release Date: June 6, 2014

Related Announcements
PAR-14-245

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On June 4, 2014, the NHLBI issued Funding Opportunity Announcement (FOA) PAR-14-245 "Translational Programs in Lung Diseases (P01)." This Notice provides details for applicants regarding additional information on eligibility and on review criteria.

The following sections of the FOA are revised accordingly:

Part 2. Full Text of Announcement

Section III. Eligibility Information

3. Additional Information on Eligibility

Current Language:

Renewals or new applications applying directly for the second cycle: At least 50% of the program project must be clinical research unless requesting a specific exception for preclinical development activities. Cycle II applicants, see Section I for requesting an exception.

Revised Language:

Renewals or new applications applying directly for the second cycle: At least 50% of the program project must be clinical research unless requesting a specific exception for preclinical development activities. Cycle II applicants, see Section IV.2 for requesting an exception.

Inquiries

Please direct all inquiries to:

Patricia Noel, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0202
Email: noelp@nih.gov

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.